Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Pediatr Rheumatol Online J ; 21(1): 96, 2023 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-37679749

RESUMO

BACKGROUND: Systemic juvenile idiopathic arthritis (systemic JIA) is a severe disease with both systemic and joint inflammation. This study aims to identify predictors of disease evolution within the systemic JIA population enrolled in the Juvenile Inflammatory Rheumatism cohort (JIRcohort). METHODS: Observational patient cohort study with 201 recruited children from 4 countries (3 European, 1 North Africa) from 2005 until 2019, using retrospectively (2005-2015) and prospectively (2015-2019) routine care collected data. RESULTS: Sixty-five patients with complete follow-up data for 24 months after first diagnosis were classified as monophasic (n = 23), polyphasic (n = 6) or persistent group (n = 36) corresponding to their evolution (unique flare, recurrent flares, or persistent disease activity respectively). The patients of the persistent group were more likely to have an earlier disease onset, before the age of 6 (OR 2.57, 95%-CI 0.70-9.46), persistence of arthritis at 12-months post-diagnosis (OR 4.45, 95%-CI 0.58-34.20) and higher use of synthetic DMARD (sDMARD, OR 5.28, 95%-CI 1.39-20.01). Other variables like global assessment by physician and by patient and C Reactive Protein levels at 12-months post-diagnosis were assessed but without any predictive value after adjusting for confounding factors. CONCLUSIONS: Our results suggest that the earlier disease onset, the persistence of arthritis throughout the first year of disease evolution and the need of sDMARD might predict a persistent disease course.


Assuntos
Antirreumáticos , Artrite Juvenil , Criança , Humanos , Artrite Juvenil/tratamento farmacológico , Estudos Retrospectivos , Antirreumáticos/uso terapêutico , Estudos de Coortes , Coleta de Dados
2.
G Chir ; 15(3): 119-23, 1994 Mar.
Artigo em Italiano | MEDLINE | ID: mdl-8060778

RESUMO

A case of Tietze's syndrome in a 62-year-old man and a critical up-to-date review of the literature are reported. Although the etiology of the disease is unknown, it has been suggested that recurrent microtrauma of the anterior chest wall may be implied in the development of characteristic degenerative changes involving single or multiple upper costochondral junction. The syndrome described by Tietze has been more commonly found in older people than previously reported and it seems to be no sex or side prevalence. Because of the benign nature of this disease and its excellent prognosis, the treatment is usually symptomatic. The accumulated data stress the importance of a thorough clinical investigation and the need to exclude severe and lifethreatening conditions in the elderly.


Assuntos
Síndrome de Tietze , Fatores Etários , Humanos , Masculino , Pessoa de Meia-Idade , Síndrome de Tietze/diagnóstico
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa